Four major pharmaceutical companies reached a settlement of 260 million euros at the last minute because of their role in the opiate crisis in the United States. As a result, the first federal lawsuit on this subject does not start.

These are the companies AmerisourceBergen, Cardinal Health, McKesson and Teva Pharmaceutical Industries.

The case, which was filed by two regions in the state of Ohio, has now been discontinued. The prosecutor in the case states in a statement that the settlement "has been an important step in the fight against the opiate crisis".

The distribution of prescription drugs available at pharmacies is largely in the hands of the first three companies. For example, it is about painkillers that can be very addictive.

In 2017, President Donald Trump declared the drug epidemic a national disaster. The opiate crisis in the US has not only caused hundreds of thousands of victims, but has also led to significant financial damage.

The total costs of the opiate crisis amounted to a total of 631 billion dollars (565 billion euros) between 2015 and 2018, according to a report by the Society of Actuaries (STD) this weekend.

See also: Many people addicted to strong painkillers, how do you get rid of it?